Elsevier announces Cell Press full text now available on ScienceDirect
Thirty years of prestigious backfiles in biological sciences now online.
Amsterdam, 4 June 2004 – Elsevier announces the launch of the prestigious Cell Press journal collection on its premier electronic platform, ScienceDirect®. Researchers across the globe will have the ability to access and cross-reference the most important titles in the fields of cellular and molecular biology, neuroscience, and immunology, including backfiles dating back to the journals’ inception – all from the convenience of their desktop.
Elsevier’s premium imprint for life science research serves as an essential and extremely valuable resource for researchers. Cell Press publishes a collection of nine leading journals – Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure and Chemistry & Biology. Each Cell Press title is at or near the top of its ISI subject category. Cell -with a current Impact Factor of 27.254 according to the 2002 ISI Journal Citation Report- has been the top research journal in the cell biology and biochemistry and molecular biology categories, 6 of the last 7 years. Similar impressive statistics apply to Neuron and Immunity in their respective categories. Newer titles like Molecular Cell, Developmental Cell, and Cancer Cell have quickly established themselves as top tier journals within their respective communities.
A passion for publishing highest-quality research is shared by all journals in the Cell Press collection. Also accessible are these titles’ long-awaited backfiles. Available online for the first time, they contain over 12,000 articles highlighting important historic developments in this field dating back to 1974.
The launch of the Cell Press journals and their backfiles on ScienceDirect marks a milestone for the imprint. “These unique articles highlight important historic developments in the field of cellular and molecular biology,” says Keith Wollman, Director Operations and Online Publishing, Cell Press. “Readers of Cell have been consistently exposed to cutting-edge research such as the sequencing of HIV, the discovery of pheromone receptors, and more recently the potential for reversing Huntington’s degeneration.”
The integration of the Cell Press journals into ScienceDirect is a welcome improvement for researchers. Joep Verheggen, Director of ScienceDirect explains, “Each new issue generates a high volume of traffic when its content is posted. Making the content available via ScienceDirect will give existing Cell Press customers a single, stable environment. With ScienceDirect a broader range of users will benefit from this highly-cited content and they can quickly and easily link out to other publisher’s content via CrossRef.”
The integration marks another milestone for ScienceDirect. Its extensive and unique full text collection now covers over 1900 journals from the core scientific literature including titles such as THE LANCET, Physics Letters B and Tetrahedron. With ScienceDirect the research process is enhanced with state-of-the-art searching and linking functionality all on a single, intuitive interface.
About Cell Press
The Cell Press collection includes nine premier journals - Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, and Chemistry & Biology. Each Cell Press journal helps to redefine important areas of science by publishing cutting-edge research papers and insightful reviews. The journals are among the most prestigious and highly cited publications in the life sciences, with each title viewed as a ‘must-read’ by the scientific community it serves.
About Science Direct
Over a quarter of the world’s full text scientific, technical and medical (STM) articles – managed by renowned editors, written by respected authors and read by researchers from around the globe – are available in one place: ScienceDirect. Elsevier’s extensive and unique full text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Almost 6 million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts.
The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 1,800 journals published by Elsevier and dynamic linking to journals from approximately 170 leading STM publishers through CrossRef. An expanding suite of scientific full text and abstract databases in a rich linking environment provides subscribers with increasingly flexible and extensive access to the world's published STM literature. An expanding program of online major reference works and book series in all fields of science seamlessly interlinks with primary research referenced in journal articles.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.